MedPath

sefulness of New Quick Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism

Not Applicable
Conditions
Primary aldosteronism
Registration Number
JPRN-UMIN000007440
Lead Sponsor
Department of internal medicine,Kanazawa University Graduate School of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

1)patients with primary aldosteronism who are not candidtes for surgery 2)patients under dialysis or with serum creatinine >2.5 mg/dl in men or >2.0 mg/dl in women 3)pregnancy or breast feeding 4)with malignancy 5)with severe hypersensitivity or with corticoid therapy 6)inadequacy to participate in the study, as assessed by the investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success rate of AVS
Secondary Outcome Measures
NameTimeMethod
1)effects on differential diagnosis of PA. 2)effects on turn-round time of AVS. 3)rares of complications 4)cost for new quick cortisol assay
© Copyright 2025. All Rights Reserved by MedPath